← Back
$DNTH All transactions

Dianthus Therapeutics, Inc. /DE/

M 10b5-1 Plan

$ Value

$276K

Shares

12,500

Price

$22

Filed

Mar 13

Insider

Name

Randhawa Simrat

Title

EVP, Head of R&D

CIK

0001992260

Roles

Officer

Transaction Details

Transaction Date

2026-03-12

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

33,830

Footnotes

The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on August 14, 2025. | The shares of common stock underlying this stock option award vested as to 25% of the shares on April 25, 2023, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date. | The shares of common stock underlying this stock option award vest in equal monthly installments over the four years after January 1, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date. | The shares of common stock underlying this stock option award vest in equal monthly installments over the four years after May 1, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date. | The shares of common stock underlying this stock option award vest in equal monthly installments over the four years after January 1, 2025, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

Filing Info

Accession No.

0001992260-26-000004

Form Type

4

Issuer CIK

0001690585

Randhawa Simrat's History

Date Ticker Type Value
2026-03-12 DNTH M $68K
2026-03-12 DNTH M $89K
2026-03-12 DNTH M $181K
2026-03-12 DNTH M $276K
2026-03-12 DNTH $2.8M
2026-03-12 DNTH M $0
2026-03-12 DNTH M $0
2026-03-12 DNTH M $0
2026-03-12 DNTH M $0
2026-02-03 DNTH A $0

Other Insiders at DNTH (90d)

Insider Bought Sold Last
CARR EDWARD
CHIEF ACCOUNTING OFFICER
$3.6M 2026-03-12
Garcia Marino
CEO AND PRESIDENT
$10.0M 2026-03-16
Soteropoulos Paula $2.2M 2026-03-31
Veness Adam M
SVP, General Counsel and Sec.
2026-02-03
Randhawa Simrat
EVP, Head of R&D
$2.8M 2026-03-12
Savitz Ryan
EVP, CFO & CBO
$10.2M 2026-04-09